Coffin-Lowry syndrome: Clinical and molecular features

Journal of Medical Genetics

Volumn 39, Issue 10, 2002, Pages 705-713

  Hanauer, A ^a   Young, I D ^b  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; CHILD; CLINICAL FEATURE; COFFIN LOWRY SYNDROME; FEMALE; HUMAN; HYPERTELORISM; KYPHOSIS; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MOLECULAR GENETICS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SCOLIOSIS; X CHROMOSOME LINKAGE;

EID: 0036793859     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.39.10.705     Document Type: Review

References (67)

1. Coffin GS, Siris E, Wegenkia LC. Mental retardation with osteocartilaginous anomalies. Am J Dis Child 1966;112:205-13.
2. Lowry B, Miller JR, Fraser FC. A new dominant gene mental retardation syndrome. Am J Dis Child 1971;121:496-500.
3. Temtamy SA, Miller JD, Hussels-Maumenee I. The Coffin-Lowry syndrome: an inherited faciodigital mental retardation syndrome. J Pediatr 1975;86:724-31.
4. Hanauer A, Alembik Y, Gilgenkrantz S, Mujica P, Nivelon-Chevallier A, Pembrey ME, Young ID, Mandel JL. Probable localisation of the Coffin-Lowry locus in Xp22.2-p22.1 by multipoint linkage analysis. Am J Med Genet 1988;30:523-30.
5. Trivier E, De Cesare D, Jacquot S, Pannetier S, Zackai E, Young I, Mandel JL, Sassone-Corsi P, Hanauer A. Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome. Nature 1996;384:567-70.
6. Delauney JP, Abidi F, Zeniou M, Jacquot S, Merienne K, Pannetier S, Schmitt M, Schwartz CE, Hanauer A. Mutations in the X-linked RSK2 gene (RPS6KA3) in patients with Coffin-Lowry syndrome. Hum Mutat 2001;17:103-16.
7. Manouvrier-Hanu S, Amiel J, Jacquot S, Merienne K, Moerman A, Coëslier A, Labarriere F, Vallée L, Croquette MF, Hanauer A. Unreported RSK2 missense mutation in two male sibs with an unusually mild form of Coffin-Lowry syndrome. J Med Genet 1999;26:775-8.
8. Merienne K, Jacquot S, Pannetier S, Zeniou M, Bankier A, Gecz J, Mandel JL, Mulley J, Sassone-Corsi P, Hanauer A. A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation. Nat Genet 1999;22:13-14.
9. Martinelli B, Campailla E. Contributo alla conoscenza della sindrome di Coffin Siris Wegienka: report of a case. G Psichiatr Neuropatol 1969;97:449-58.
10. Procopis PG, Turner B. Mental retardation, abnormal fingers, and skeletal anomalies; Coffin's syndrome. Am J Dis Child 1972;124:258-61.
11. Fryns JP, Vinken L, van den Berghe H. The Coffin syndrome. Hum Genet 1977;36:271-6.
12. Wilson WG, Kelly TE. Early recognition of the Coffin-Lowry syndrome. Am J Med Genet 1981;8:215-20.
13. Hunter AGW, Partington MW, Evans JA. The Coffin-Lowry syndrome. Experience from four centres. Clin Genet 1982;21:321-35.
14. Haspeslagh M, Fryns JP, Beusen L, Van Dessel F, Vinken L, Moens E, Van Den Berghe H. The Coffin-Lowry syndrome. A study of two new index patients and their families. Eur J Pediatr 1984;143:82-6.
15. Collacott RA, Warrington JS, Young I D. Coffin-Lowry syndrome and schizophrenia: a family report. J Ment Defic Res 1987;31:199-207.
16. Kousseff BG. Coffin-Lowry syndrome in an Afro-American family. Am J Med Genet 1982;11:373-5.
17. Gilgenkrantz S, Mujica P, Gruet P, Tridon P, Schweitzer F, Nivelon-Chevallier A, Nivelon JL, Couillault G, David A, Verloes A, Lambotte C, Piussan CP, Mathieu M. Coffin-Lowry syndrome: a multicenter study. Clin Genet 1988;34:230-45.
18. Partington MW, Mulley JC, Sutherand GR, Thode A, Turner G. A family with the Coffin-Lowry syndrome revisited: localization of CLS to Xp21-pter. Am J Med Genet 1988;30:509-21.
19. Plomp AS, De Die-Smulders CEM, Meinecke P, Ypma-Verhulst JM, Lissone DA, Fryns JP. Coffin-Lowry syndrome: clinical aspects at different ages and symptoms in female carriers. Genet Couns 1995;6:259-68.
20. Hersh JH, Weisskopf B, DeCoster C. Forearm fullness in Coffin-Lowry syndrome: a misleading yet possible early diagnostic due. Am J Med Genet 1984;18:185-9.
21. Padley S, Hodgson SV, Sherwood T. The radiology of Coffin-Lowry syndrome. Br J Radiol 1990;63:72-5.
22. Hartsfield JK, Hall BD, Grix AW, Kousseff BG, Salazar JF, Haufe SMW. Pleiotropy in Coffin-Lowry syndrome: sensorineural hearing deficit and premature tooth loss as early manifestations. Am J Med Genet 1993;45:552-7.
23. Sivagamasundari U, Fernando H, Jardine P, Rao JM, Lunt P, Jayewardene SLW. The association between Coffin-Lowry syndrome and psychosis: a family study. J Intell Dis Res 1994;38:469-73.
24. Machin GA, Walther GL, Fraser VM. Autopsy findings in two adult siblings with Coffin-Lowry syndrome. Am J Med Genet 1987;suppl 3:303-9.
25. Krajewska-Walasek M, Kubicka K, Ryzko J. Cardiac involvement in Coffin-Lowry syndrome. Eur J Pediatr 1988;147:448.
26. Massin MM, Radermecker MA, Verloes A, Jacquot S, Grenade T. Cardiac involvement in Coffin-Lowry syndrome. Acta Paediatr 1999;88:468-70.
27. Nakamura M, Yamagata T, Momoi MY, Yamazaki T. Drop episodes in Coffin-Lowry syndrome: exaggerated startle responses treated with clonazepam. Pediatr Neurol 1998;19:148-50.
28. Crow YJ, Zuberi SM, McWilliam R, Tolmie JL, Hollmann A, Pohl K, Stephenson JBP. "Cataplexy" and muscle ultrasound abnormalities in Coffin-Lowry syndrome. J Med Genet 1998;35:94-8.
29. Ishida Y, Oki T, Ono Y, Nogami H. Coffin-Lowry syndrome associated with calcium pyrophosphate crystal deposition in the ligamenta flava. Clin Orthop Rel Res 1992;275:144-51.
30. Biancalana V, Briard ML, David A, Gilgenkrantz S, Kaplan J, Mathieu M, Piussan C, Poncin J, Schintzel A, Oudet C, Hanauer A. Confirmation ond refinement of the genetic localization of the Coffin-Lowry syndrome locus in Xp22.1-p22.2. Am J Hum Genet 1992;50:981-7.
31. Biancalana V, Trivier E, Weber C, Weissenbach J, Rowe PS, O'Riordan JL, Partington MW, Heyberger S, Oudet C, Hanauer A. Construction of a high-resolution linkage map for Xp22.1-p22.2 and refinement of the genetic localization of the Coffin-Lowry syndrome gene. Genomics 1994;22:617-25.
32. Jacquot S, Merienne K, De Cesare D, Pannetier S, Mandel JL, Sassone-Corsi P, Hanauer A. Mutation analysis of the RSK2 gene in Coffin-Lowry patients: extensive allelic heterogeneity and a high rate of de novo mutations. Am J Hum Genet 1998;63:1631-40.
33. Erikson E, Maller JL. A protein kinase from Xenopus eggs specific for ribosomal protein S6. Proc Natl Acad Sci U S A 1985;82:742-6.
34. von Manteuffel SR, Dennis PB, Pullen N, Gingras AC, Sonenberg N, Thomas G. The insulin-induced signalling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70s6k. Mol Cell 1997;17:5426-36.
35. Grove JR, Price DJ, Banerjee P, Balasubramanyam A, Ahmad MF, Avruch J. Protein regulation of an epitope-tagged recombinant Rsk-1 S6 kinase by phorbol ester and erk/MAP kinase. Biochemistry 1993;32:7727-38.
36. Wassarman DA, Solomon NM. Rubin GM. The Drosophila melanogaster ribosomal S6 kinase II-encoding sequence. Gene 1994;144:309-10.
37. Zhao Y, Bjorbaek C, Weremowicz S, Morton CC, Moller DE. RSK3 encodes a novel pp90rsk isoform with a unique N-terminal sequence: growth factor-stimulated kinase function and nuclear translocation. Mol Cell Biol 1995;15:4353-63.
38. Sutherland C, Alterio J, Campbell DG, Le Bourdelles B, Mallet J, Haavik J, Cohen P. Phosphorylation and activation of human tyrosine hydroxylase in vitro by mitogen-activated protein (MAP) kinase and MAP-kinase-activated kinases 1 and 2. Eur J Biochem 1993;217:715-22.
39. Bjorbaek C, Vik TA, Echwald SM, Yang, PY, Vestergaard H, Wang JP, Webb GC, Richmond K, Hansen T, Erikson RL, Gabor-Miklos GL, Cohen PTW, Pederson O. Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA levels of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients. Diabetes 1995;44:90-7.
40. Fisher TL, Blenis J. Evidence for two catalytically active kinase domains in pp90rsk. Mol Cell Biol 1996; 16:1212-19.
41. Dalby KN, Morrice N, Caudwell FB, Avruch J, Cohen P. Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. J Biol Chem 1998;273:1496-505.
42. Smith JA, Poteet-Smith CE, Malarkey K, Sturgill TW. Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J Biol Chem 1999;274:2893-8.
43. Vik TA, Ryder JW. Identification of serine 380 as the major site of autophosphorylation of Xenopus pp90rsk. Biochem Biophys Res Commun 1997;235:398-402.
44. Frödin M, Jensen CJ, Merienne K, Gammeltoft S. A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1. EMBO J 2000;19:2924-34.
45. Leighton IA, Dalby KN, Caudwell FB, Cohen PT, Cohen P. Comparison of the specificities of p70 S6 kinase and MAPKAP kinase-1 identifies a relatively specific substrate for p70 S6 kinase: the N-terminal kinase domain of MAPKAP kinase-1 is essential for peptide phosphorylation. FEBS Lett 1995;375:289-93.
46. Blenis J. Signal transduction via the MAP kinases; proceed at your own RSK. Proc Natl Acad Sci USA 1993;90:5889-92.
47. Frodin M, Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 1999;25:65-77.
48. Nakajima T, Fukamizu A, Takahashi J, Gage FH, Fisher T, Blenis J, Montminy MR. The signal-dependent coactivator CBP is a nuclear target for pp90RSK. Cell 1996;86:465-74.
49. De Cesare D, Jacquot S, Hanauer A, Sassone-Corsi P. Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc Natl Acad Sci USA 1998;95:12202-7.
50. Sassone-Corsi P, Mizzen CA, Cheung P, Crosio C, Monaco L, Jacquot S, Hanauer A, Allis CD. Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3. Science 1999;285:886-90.
51. Yntema HG, van den Helm B, Kissing J, van Duijnhoven G, Poppelaars F, Chelly J, Moraine C, Fryns JP, Hamel BC, Heilbronner H, Pander HJ, Brunner HG, Ropers HH, Cremers FP, van Bokhoven H. A novel ribosomal S6-kinase (RSK4; RPS6KA6) is commonly deleted in patients with complex X-linked mental retardation. Genomics 1999;15:332-43.
52. Abidi F, Jacquot S, Lassiter C, Trivier E, Hanauer A, Schwartz CE. Novel mutations in Rsk-2, the gene for Coffin-Lowry syndrome (CLS). Eur J Hum Genet 1999;7:20-6.
53. Jacquot S, Merienne K, Pannetier S, Blumenfeld S, Schinzel A, Hanauer A. Germline mosaicism in Coffin-Lowry syndrome. Eur J Hum Genet 1998;6:578-82.
54. Horn D, Delaunoy JP, Kunze J. Prenatal diagnosis in Coffin-Lowry syndrome demonstrates germinal mosaicism confirmed by mutation analysis. Prenat Diagn 2001;21:1-4.
55. Donnelly AJ, Choo KH, Kozman HM, Gedeon AK, Danks DM, Mulley JC. Regional localisation of a non-specific X-linked mental retardation gene (MRX19) to Xp22. Am J Med Genet 1994;51:581-5.
56. Zeniou M, Pannetier S, Fryns JP, Hanauer A. Unusual splice-site mutations in the RSK2 gene and suggestion of genetic heterogeneity in Coffin-Lowry syndrome. Am J Hum Genet 2002;70:1421-33.
57. McCandless SE, Schwartz S, Morrison S, Garlapati K, Robin NH. Adult with an interstitial deletion of chromosome 10 (del(10)(q25. 1q25.3)): overlap with Coffin-Lowry syndrome. Am J Med Genet 2000;13:93-8.
58. Merienne K, Jacquot S, Trivier E, Pannetier S, Rossi A, Schinzel A, Castellan C, Kress W, Hanauer A. Rapid immunoblot and kinase assay tests for a syndromal form of X-linked mental retardation: Coffin-Lowry syndrome. J Med Genet 1998;35:890-4.
59. Atkins CM, Selcher JC, Petraitis JJ, Trzaskos JM, Sweatt JD. The MAPK cascade is required for mammalian associative learning. Nat Neurosci 1998;1:602-9.
60. Blum S, Moore AN, Adams F, Dash PK. A mitogen-activated protein cascade in the CA1/CA2 subfield of the dorsal hippocampus is essential for long-term spatial memory. J Neurosci 1999;19:3535-44.
61. Gass P, Wolfer DP, Balschun D, Rudolph D, Frey U, Lipp HP, Schutz G. Deficits in memory tasks of mice with CREB mutations depend on gene dosage. Learn Mem 1998;5:274-88.
62. Silva AJ, Kogan JH, Frankland PW, Kida S. CREB and memory. Annu Rev Neurosci 1998;21:127-48.
63. Bliss TVP, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993;361:31-9.
64. Impey S, Smith DM, Obrietan K, Donahue R, Wade C, Storm DR. Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning. Nat Neurosci 1998;1:595-601.
65. Husi H, Ward MA, Choudhary JS, Blackstock WP, Grant SG. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat Neurosci 2000;3:661-9.
66. Wang ZQ, Ovitt C, Grigoriadis AE, Mohle-Steinlein U, Ruther U, Wagner EF. Bone and haematopoietic defects in mice lacking c-fos. Nature 1992;360:741-5.
67. Dufresne SD, Bjorbaek C, El-Haschimi K, Zhao Y, Aschenbach WG, Moller DE, Goodyear LJ. Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice. Mol Cell Biol 2001;21:81-7.